Aug 3 2012

From The Space Library

Revision as of 15:32, 20 March 2014 by RobertG (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

RELEASE: 12-254 NASA INVESTIGATES PROTON RADIATION EFFECTS ON CELLS

HOUSTON -- A team of researchers at NASA's Johnson Space Center in Houston and Lawrence Berkeley National Laboratory in Berkeley, Calif., has found radiation from protons could further enhance a process that occurs during tumor progression. This information may help lead to better methods to protect astronauts from the harmful effects of radiation in space, as well as help cancer researchers on Earth better understand the effects of radiation treatment on the human body. NASA is particularly interested in this research because protons, which are charged subatomic particles, are the main source of space radiation astronauts receive during spaceflights. The study was part of NASA's ongoing effort to learn how to mitigate the effects of radiation during long-duration missions to destinations beyond low Earth orbit, such as asteroids and Mars. "Our paper makes new discoveries on the potential risks from low doses of protons that occur outside of the tumor during radiation therapy, and to all tissues for astronauts exposed to space radiation," said Francis A. Cucinotta, chief scientist for the Human Research Program Space Radiation Program Element at Johnson and one of the authors of the paper. The objective of the researchers was to study the biological effects of low-energy protons on epithelial cells (membranous tissues found throughout the body) and the protons' propensity to enhance a process that occurs during tumor progression. This process is called epithelial-mesenchymal transition (EMT), which has been associated with cancer progression. EMT also has been linked to radiation-induced fibrosis, one of the most common late effects of radiotherapy. Notably, the study revealed protons alone can induce EMT-associated changes in normal human epithelial cells. Although the total body dose received in space is moderately low compared to what is received in radiotherapy, this study reveals that low doses of protons still may prompt EMT and result in potentially detrimental effects. These studies were conducted at Johnson and at the NASA Space Radiation Laboratory at Brookhaven National Laboratory, Upton, N.Y. Results of the study were published as "Protons Sensitize Epithelial Cells to Mesenchymal Transition" in the July 23 issue of the journal PLoS ONE.

MEDIA ADVISORY: C12-032 NASA SELECTS CONSTRUCTION CONTRACTS AT STENNIS

WASHINGTON -- NASA has selected six indefinite delivery/indefinite quantity multiple award construction contracts at the agency's Stennis Space Center near Bay St. Louis, Miss. The fixed price contracts consist of a performance period of five years, with a total value not to exceed $700 million. The companies selected are as follows: --Advon Corporation, Tallahassee, Fla. --Birmingham Industrial Construction LLC, Birmingham, Ala. --Harry Pepper & Associates Inc., Jacksonville, Fla. --McClain Contracting Company Inc., Andalusia, Ala. --MOWA Development LLC, Gautier, Miss. --Sauer Incorporated, Jacksonville, Fla. Work under the contract may include but will not be limited to maintenance, repair, alteration, mechanical, civil, electrical, heating/air conditioning, demolition, painting, earthwork, fencing, steel fabrication and or welding. Additional work also may include but will not be limited to design/build projects, as well as new construction of buildings or facilities.

RELEASE: 12-263 NASA ANNOUNCES NEXT STEPS IN EFFORT TO LAUNCH AMERICANS FROM U.S. SOIL

CAPE CANAVERAL, Fla. -- NASA Friday announced new agreements with three American commercial companies to design and develop the next generation of U.S. human spaceflight capabilities, enabling a launch of astronauts from U.S. soil in the next five years. Advances made by these companies under newly signed Space Act Agreements through the agency's Commercial Crew Integrated Capability (CCiCap) initiative are intended to ultimately lead to the availability of commercial human spaceflight services for government and commercial customers.? CCiCap partners are: -- Sierra Nevada Corporation, Louisville, Colo., $212.5 million -- Space Exploration Technologies (SpaceX), Hawthorne, Calif., $440 million -- The Boeing Company, Houston, $460 million "Today, we are announcing another critical step toward launching our astronauts from U.S. soil on space systems built by American companies," NASA Administrator Charles Bolden said at the agency's Kennedy Space Center in Florida. "We have selected three companies that will help keep us on track to end the outsourcing of human spaceflight and create high-paying jobs in Florida and elsewhere across the country." CCiCap is an initiative of NASA's Commercial Crew Program (CCP) and an administration priority. The objective of the CCP is to facilitate the development of a U.S. commercial crew space transportation capability with the goal of achieving safe, reliable and cost-effective access to and from the International Space Station and low Earth orbit. After the capability is matured and expected to be available to the government and other customers, NASA could contract to purchase commercial services to meet its station crew transportation needs. The new CCiCAP agreements follow two previous initiatives by NASA to spur the development of transportation subsystems, and represent the next phase of U.S. commercial human space transportation, in which industry partners develop crew transportation capabilities as fully integrated systems. Between now and May 31, 2014, NASA's partners will perform tests and mature integrated designs. This would then set the stage for a future activity that will launch crewed orbital demonstration missions to low Earth orbit by the middle of the decade. "For 50 years American industry has helped NASA push boundaries, enabling us to live, work and learn in the unique environment of microgravity and low Earth orbit," said William Gerstenmaier, associate administrator for the Human Exploration and Operations Mission Directorate at NASA Headquarters in Washington. "The benefits to humanity from these endeavors are incalculable. We're counting on the creativity of industry to provide the next generation of transportation to low Earth orbit and expand human presence, making space accessible and open for business." While NASA works with U.S. industry partners to develop commercial spaceflight capabilities to low Earth orbit, the agency also is developing the Orion Multi-Purpose Crew Vehicle (MPCV) and the Space Launch System (SLS), a crew capsule and heavy-lift rocket to provide an entirely new capability for human exploration. Designed to be flexible for launching spacecraft for crew and cargo missions, SLS and Orion MPCV will expand human presence beyond low Earth orbit and enable new missions of exploration across the solar system.